<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR37">
 <label>37.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jinno</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Tanaka-Kagawa</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Hanioka</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Saeki</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Ishida</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Nishimura</surname>
    <given-names>T</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D</article-title>
  <source>Drug Metab Dispos</source>
  <year>2003</year>
  <volume>31</volume>
  <fpage>108</fpage>
  <lpage>113</lpage>
  <pub-id pub-id-type="doi">10.1124/dmd.31.1.108</pub-id>
  <?supplied-pmid 12485959?>
  <pub-id pub-id-type="pmid">12485959</pub-id>
 </element-citation>
</ref>
